Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
-
-
GW Hospital used VR technology to see into COVID-19 patient’s lungs
On Apr. 2, 2020, George Washington University Hospital announced it had used Virtual Reality technology to see into…
-
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
-
UW-Madison, FluGen and Bharat Biotech announced development of CoroFlu, a coronavirus vaccine
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…
-
The FDA announced publication of ARGOS SARS-CoV-2 reference grade sequence data
On Apr. 2, 2020, the FDAﾗin collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository…
-
Early study of COVID-19 patients showed high mortality rate
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
-
Biotechnology | Genomics | NIH | Rare Disease | Therapeutics
NIH researchers discovered gene for rare disease of excess bone tissue growth
On Mar. 31, 2020, researchers at the National Institutes of Health announced they had discovered a second gene…
-
Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
-
Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated delivery
On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the U.S….
-
Vaxart provided update on its oral COVID-19 vaccine program
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
-
Amyris scaled up in response to high need for hand sanitizer and wipe products
On Mar. 31, 2020, Amyris announced that initial production of its hand sanitizer has started with Allure Labs…
-
Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidates
On Mar. 31, 2020, Sorrento announced it had entered into a research testing agreement with The University of…
-
Cue Health awarded $13 million for rapid, portable, point-of-Care COVID-19 test by BARDA
On Mar. 31, 2020, Cue Health announced that is had been awarded up to $30 million in base…
-
Kleo Pharmaceuticals announced research collaboration with Green Cross LabCell to develop COVID-19-targeting allogeneic NK Cell combination therapy
On Mar. 31, 2020, Kleo Pharmaceuticals announced it had entered into a research collaboration with South Korea -based…
-
Mayo Clinic in Florida expanded specimen testing and processing capabilities for COVID-19
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
-
BD, BioMedomics announced launch of rapid serology test to detect exposure to COVID-19
On Mar. 31, 2020, BD (Becton, Dickinson and Company) and BioMedomics announced the release of a new point-of-care…
-
Emergent BioSolutions signed agreement with Novavax to manufacture NanoFlu
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent provided molecule-to-market contract development and…
-
University of Minnesota researchers orchestrated state’s fastest on-site testing for COVID-19
On Mar. 31, 2020, the University of Minnesota announced that the Medical School transformed two research buildings to…
-
Luminex received BARDA contract to support development of second, rapid SARS-CoV-2 test
On Mar. 31, 2020, Luminex announced it had received $642,450 in funding from the Biomedical Advanced Research and…
-
Amgen established Amgen Astellas BioPharma as wholly-owned affiliate In Japan
On Mar. 31, 2020, Amgen announced it had consummated the purchase from Astellas of 49% of shares of…
-
The USNS Comfort joined New York’s COVID-19 fight
On Mar. 30, 2020, the Military Sealift Command hospital ship USNS Comfort (T-AH 20) arrived in New York…
-
NIH-funded studies showed stents and surgery no better than medication, lifestyle changes at reducing cardiac events
On Mar. 30, 2020, invasive procedures such as bypass surgery and stenting-commonly used to treat blocked arteries were…
-
Bayer increased Germany’s COVID-19 analysis capacity by several thousand tests per day
On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its…
-
Biotechnology | Diagnostics | Infectious Disease | Medicine | Non-Profit Research | Therapeutics | Vaccine
Citizen scientists helped researchers design new drugs to combat COVID-19
On Mar. 30, 2020, Howard Hughes Medical Institute Investigator David Baker created new proteins tailor-made for specific tasks….
-
COVID-19 Therapeutics Accelerator awarded $20 million in initial grants to fund clinical trials
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…
-
La Jolla Institute for Immunology hosted coronavirus immunotherapy clearinghouse
On Mar. 30, 2020, the La Jolla Institute for Immunology (LJI) announced it had been awarded a $1.73…
-
Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccine
On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…
-
University of Minnesota researchers revealed how the novel coronavirus binds to human cells
On Mar. 30, 2020, researchers from the University of Minnesota broke new ground in understanding how SARS-CoV-2, the…
-
Johnson & Johnson announced a lead vaccine candidate for COVID-19
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
